These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

215 related items for PubMed ID: 12234839

  • 1. Comparison of the in vitro activity of the glycylcycline tigecycline (formerly GAR-936) with those of tetracycline, minocycline, and doxycycline against isolates of nontuberculous mycobacteria.
    Wallace RJ, Brown-Elliott BA, Crist CJ, Mann L, Wilson RW.
    Antimicrob Agents Chemother; 2002 Oct; 46(10):3164-7. PubMed ID: 12234839
    [Abstract] [Full Text] [Related]

  • 2. In Vitro Antimicrobial Activities of Tigecycline, Eravacycline, Omadacycline, and Sarecycline against Rapidly Growing Mycobacteria.
    Zhang T, Du J, Dong L, Wang F, Zhao L, Jia J, Wang C, Cheng M, Yu X, Huang H.
    Microbiol Spectr; 2023 Feb 14; 11(1):e0323822. PubMed ID: 36475850
    [Abstract] [Full Text] [Related]

  • 3. Synergistic activities of tigecycline with clarithromycin or amikacin against rapidly growing mycobacteria in Taiwan.
    Huang CW, Chen JH, Hu ST, Huang WC, Lee YC, Huang CC, Shen GH.
    Int J Antimicrob Agents; 2013 Mar 14; 41(3):218-23. PubMed ID: 23312605
    [Abstract] [Full Text] [Related]

  • 4. In Vitro Susceptibility Testing of Eravacycline against Nontuberculous Mycobacteria.
    Brown-Elliott BA, Wallace RJ.
    Antimicrob Agents Chemother; 2022 Sep 20; 66(9):e0068922. PubMed ID: 35943269
    [Abstract] [Full Text] [Related]

  • 5. In Vitro Susceptibility Testing of Omadacycline against Nontuberculous Mycobacteria.
    Brown-Elliott BA, Wallace RJ.
    Antimicrob Agents Chemother; 2021 Feb 17; 65(3):. PubMed ID: 33288634
    [Abstract] [Full Text] [Related]

  • 6. Activities of the glycylcyclines N,N-dimethylglycylamido-minocycline and N,N-dimethylglycylamido-6-demethyl-6-deoxytetracycline against Nocardia spp. and tetracycline-resistant isolates of rapidly growing mycobacteria.
    Brown BA, Wallace RJ, Onyi G.
    Antimicrob Agents Chemother; 1996 Apr 17; 40(4):874-8. PubMed ID: 8849243
    [Abstract] [Full Text] [Related]

  • 7. Multisite reproducibility of results obtained by the broth microdilution method for susceptibility testing of Mycobacterium abscessus, Mycobacterium chelonae, and Mycobacterium fortuitum.
    Woods GL, Bergmann JS, Witebsky FG, Fahle GA, Wanger A, Boulet B, Plaunt M, Brown BA, Wallace RJ.
    J Clin Microbiol; 1999 Jun 17; 37(6):1676-82. PubMed ID: 10325306
    [Abstract] [Full Text] [Related]

  • 8. Antimicrobial susceptibility testing of rapidly growing mycobacteria isolated in Japan.
    Hatakeyama S, Ohama Y, Okazaki M, Nukui Y, Moriya K.
    BMC Infect Dis; 2017 Mar 07; 17(1):197. PubMed ID: 28270102
    [Abstract] [Full Text] [Related]

  • 9. High prevalence of antimicrobial resistance in rapidly growing mycobacteria in Taiwan.
    Yang SC, Hsueh PR, Lai HC, Teng LJ, Huang LM, Chen JM, Wang SK, Shie DC, Ho SW, Luh KT.
    Antimicrob Agents Chemother; 2003 Jun 07; 47(6):1958-62. PubMed ID: 12760874
    [Abstract] [Full Text] [Related]

  • 10. In Vitro Antimicrobial Susceptibility of Nontuberculous Mycobacteria in Iran.
    Heidarieh P, Mirsaeidi M, Hashemzadeh M, Feizabadi MM, Bostanabad SZ, Nobar MG, Hashemi Shahraki A.
    Microb Drug Resist; 2016 Mar 07; 22(2):172-8. PubMed ID: 26468990
    [Abstract] [Full Text] [Related]

  • 11. [Evaluation of Antimicrobial Susceptibilities of Rapidly Growing Mycobacteria].
    Özkarataş MH, Arslan N, Esen N, Özkütük AA.
    Mikrobiyol Bul; 2023 Apr 07; 57(2):220-237. PubMed ID: 37067207
    [Abstract] [Full Text] [Related]

  • 12. Multisite reproducibility of Etest for susceptibility testing of Mycobacterium abscessus, Mycobacterium chelonae, and Mycobacterium fortuitum.
    Woods GL, Bergmann JS, Witebsky FG, Fahle GA, Boulet B, Plaunt M, Brown BA, Wallace RJ, Wanger A.
    J Clin Microbiol; 2000 Feb 07; 38(2):656-61. PubMed ID: 10655363
    [Abstract] [Full Text] [Related]

  • 13. In Vitro Activities of Omadacycline against Rapidly Growing Mycobacteria.
    Shoen C, Benaroch D, Sklaney M, Cynamon M.
    Antimicrob Agents Chemother; 2019 May 07; 63(5):. PubMed ID: 30858221
    [Abstract] [Full Text] [Related]

  • 14. Evaluation of antimicrobial susceptibilities of rapidly growing mycobacteria by Sensititre RAPMYCO panel.
    Cavusoglu C, Gurpinar T, Ecemis T.
    New Microbiol; 2012 Jan 07; 35(1):73-6. PubMed ID: 22378556
    [Abstract] [Full Text] [Related]

  • 15. In vitro activity of 11 antimicrobial agents, including gatifloxacin and GAR936, tested against clinical isolates of Mycobacterium marinum.
    Rhomberg PR, Jones RN.
    Diagn Microbiol Infect Dis; 2002 Feb 07; 42(2):145-7. PubMed ID: 11858912
    [Abstract] [Full Text] [Related]

  • 16. Antimicrobial resistance of rapidly growing mycobacteria in western Taiwan: SMART program 2002.
    Huang TS, Lee SS, Hsueh PR, Tsai HC, Chen YS, Wann SR, Leu HS, Ko WC, Yan JJ, Yuan SZ, Chang FY, Lu JJ, Wang JH, Wang HK, Liu YC.
    J Formos Med Assoc; 2008 Apr 07; 107(4):281-7. PubMed ID: 18445541
    [Abstract] [Full Text] [Related]

  • 17. In vitro susceptibility testing of tetracycline-class antibiotics against slowly growing non-tuberculous mycobacteria.
    Li A, Tan Z, He S, Chu H.
    Clin Exp Pharmacol Physiol; 2023 Jul 07; 50(7):604-609. PubMed ID: 37086075
    [Abstract] [Full Text] [Related]

  • 18. In vitro activities of tigecycline and 10 other antimicrobials against nonpigmented rapidly growing mycobacteria.
    Fernández-Roblas R, Martín-de-Hijas NZ, Fernández-Martínez AI, García-Almeida D, Gadea I, Esteban J.
    Antimicrob Agents Chemother; 2008 Nov 07; 52(11):4184-6. PubMed ID: 18725441
    [Abstract] [Full Text] [Related]

  • 19. In vitro activities of the novel oxazolidinones DA-7867 and DA-7157 against rapidly and slowly growing mycobacteria.
    Vera-Cabrera L, Brown-Elliott BA, Wallace RJ, Ocampo-Candiani J, Welsh O, Choi SH, Molina-Torres CA.
    Antimicrob Agents Chemother; 2006 Dec 07; 50(12):4027-9. PubMed ID: 17015632
    [Abstract] [Full Text] [Related]

  • 20. In vitro activities of the glycylcycline GAR-936 against gram-positive bacteria.
    Boucher HW, Wennersten CB, Eliopoulos GM.
    Antimicrob Agents Chemother; 2000 Aug 07; 44(8):2225-9. PubMed ID: 10898710
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.